M
27
-3
AIZ
82
9
DAL
28
6
HPE
19
3
KMX
54
2
MU
60
9
PNC
55
3
AME
54
6
GOOGL
45
2
MTB
63
4
BLK
49
3
SLG
44
6
CCI
54
15
PSA
60
2
INTU
58
-4
DHR
51
6
MPC
44
8
ZION
55
7
CMCSA
48
2
HP
36
3
M
27
-3
AIZ
82
9
DAL
28
6
HPE
19
3
KMX
54
2
MU
60
9
PNC
55
3
AME
54
6
GOOGL
45
2
MTB
63
4
BLK
49
3
SLG
44
6
CCI
54
15
PSA
60
2
INTU
58
-4
DHR
51
6
MPC
44
8
ZION
55
7
CMCSA
48
2
HP
36
3
Financhill
Back

Bicara Therapeutics Vs. DocuSign Industry Stock Comparison

Sell
46

BCAX
Bicara Therapeutics

Last Price:
$12.45
Seasonality Move:
--
Buy
82

DOCU
DocuSign

Last Price:
$85.72
Seasonality Move:
15.31%
Sell
46
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $12.42. The Score for BCAX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
DocuSign (DOCU) is a Buy

Is DocuSign a Buy, Sell or Hold?

  • The current DocuSign [DOCU] share price is $85.76. The Score for DOCU is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • DOCU is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $12.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.

DOCU Stock Price Chart

What is DocuSign's stock price today?

  • The DocuSign share price today is $85.76
    The current trend is relatively stagnant and DOCU is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 42.78 Sell
Chaikin Money Flow: -444852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.31 - 14.39) Sell
Bollinger Bands (100): (13 - 21.26) Sell

DOCU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.64 Sell
Relative Strength Index (14 RSI): 53.41 Buy
Chaikin Money Flow: 3107309 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.97 - 89.85) Buy
Bollinger Bands (100): (76.52 - 94.14) Buy

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.27 Sell
20-day SMA: 13.51 Sell
50-day SMA: 13.53 Sell
200-day SMA: 0 Buy
8-day EMA: 13.65 Sell
20-day EMA: 13.58 Sell
50-day EMA: 14.06 Sell
200-day EMA: 11.13 Buy

DOCU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.51 Buy
20-day SMA: 83.13 Buy
50-day SMA: 88.51 Sell
200-day SMA: 70.82 Buy
8-day EMA: 80.97 Buy
20-day EMA: 83.26 Buy
50-day EMA: 85.79 Sell
200-day EMA: 75.3 Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.

DocuSign Earnings Growth & DOCU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.04 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

DocuSign Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):